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Very little is known about the role of interleukin-1𝗽 (IL-1𝗽) and interleukin-18 (IL-18) in urticaria. Material and Methods.S e r u m
levels of IL-1𝗽, IL-1 receptor antagonist (IL-1RA), and IL-18 were measured in 56 children with urticaria and in 41 healthy subjects.
Results.SerumIL-1𝗽didnotdifferbetweenchildrenwithacuteurticariaandcontrols.Childrenwithsingleepisodeofurticariahad
higher levels of IL-1RA and IL-18 than healthy subjects. In children with single episode of urticaria, level of IL-1RA correlated with
C-reactive protein (CRP), D-dimer, and IL-1𝗽 levels. In subjects with recurrence of urticaria IL-1RA was positively correlated with
WBC and D-dimer levels. No correlation of cytokine levels and urticaria severity scores (UAS) in all children with urticaria was
observed. In children with single episode of urticaria UAS correlated with CRP level. In the group with single episode of urticaria
and in children with symptoms of upper respiratory infection, IL-1RA and IL-18 levels were higher than in controls. The former
was higher than in noninfected children with urticaria. In conclusion, this preliminary study documents that serum IL-1RA and
IL-18 levels are increased in some children with acute urticaria. However further studies are necessary to define a pathogenic role
of IL-1𝗽, IL-1RA, and IL-18 in urticaria.
1. Introduction
Urticaria is a commonly recognized skin disorder character-
ized by the sudden development of pruritic wheals and/or
angioedema. During recent years significant progress has
been made in elucidation of both the etiology and patho-
genesis of urtricaria; however, data on urticaria in children
still remain scarce and are mostly derived from extrapolat-
ing information obtained in adults [1]. Although pediatric
urticaria has a specific clinical appearance, its pathogenesis
remainspartiallyunknown.Themostcommonmanifestation
in children is acute spontaneous urticaria, affecting 4.5–15%
of this age group [2]. Infections are the main trigger factor
of acute urticaria in the pediatric age group. Allergy, drugs,
and physical factors have been implicated in pathogenesis to
a lesser extent [3]. About 20–30% of cases of acute urticaria
progress to chronic and recurrent urticaria [1].
In patients with acute urticaria independently on the age,
degranulation of cutaneous mast cells by a variety of causes
results in the release of histamine and other inflammatory
mediators which initiate local or generalized skin involve-
ment. The increase in circulating levels of general markers of
inflammation in association with the alteration of cytokine
profile has been widely documented in adult patients with
urticaria [4–11].
It has been described in recent literature that broad
spectrumofcytokinesandchemokines,includinginterleukin
1-𝗽 (IL-1𝗽) and interleukin 18 (IL-18) has been involved in
activation or modulation of the mast cells function [12, 13].
The IL-1 family includes 11 known members together
with IL-1𝗼 and IL-1𝗽 which were discovered first. IL-1𝗽 and
IL-18, are important representatives of this family, inducing
expression of an array of various proinflammatory genes
and play a central role in innate and acquired immune2 BioMed Research International
response [14, 15]. IL-1𝗽 is produced predominately in blood
monocytes,macrophages,anddendriticcells.IL-1𝗽promotes
T-cell survival, upregulates the IL-2R on lymphocyte surface,
stimulates B-lymphocytes for proliferation and antibody
production, and enhances Th17 lymphocytes differentiation
[14, 16].
The main source of IL-18 are monocytes and macropha-
ges, dendritic cells and also keratinocytes, and Langerhans’
cells and B-lymphocytes. IL-18 exerts a Th1 inflammatory
response with simultaneous costimulation with IL-12, IL-15,
or IL-2 and Th2 response without the influence of IL-12 and
IL-23. IL-18 also promotes allergic inflammation through the
activationofIL-4,IL-13,histaminerelease,andenhancedIgE
production [12, 17–19].
Both IL-1𝗽 and IL-18 require the intracellular cysteine
protease—caspase-1 for biological activity. Caspase-1 activa-
tion is mediated by a cytosolic multiprotein oligomer called
the inflammasome [20]. The activity of the inflammasome
is triggered not only by microbial infection, but also by a
widerangeofnoninfectiousbothexogenousandendogenous
stimuli. The dysregulation of inflammasome activity is asso-
ciated with numerous proinflammatory and nonmicrobial
diseases in humans [21, 22]. IL-1𝗽 and IL-18 are the pivotal
cytokines in autoinflammatory diseases such as cryopyrin-
associated periodic syndromes (CAPS) group and Schnit-
zler syndrome (SchS) which are regularly associated with
urticarial rash [23]. Recent findings also suggest that both
inflammasomedependentcytokinesareimplicatedinallergic
diseases such as asthma, atopic and contact dermatitis, and
some forms of chronic urticaria [23–27].
The IL-1 receptor antagonist (IL-1RA), another member
of IL-1 family, competitively blocks the corresponding recep-
tors reducing the inflammation response but not exerting
its own agonists activity. The balance between IL-1 and
its receptor IL-1RA plays an important role in a modula-
tion of the course of different diseases including diabetes,
overweight, chronic rheumatic diseases, sepsis, colitis, and
granulomatous pulmonary disease [28].
The possible role of IL-1𝗽 and IL-18 in acute spontaneous
urticaria has not been studied in children yet. Thus, the aim
o fo u rs t u d yw a st oa n a l y z es e r u ml e v e l so fI L - 1 𝗽 and its
competitive antagonist, IL-1RA and IL-18 in children with
acute spontaneous urticaria.
2. Material and Methods
Thestudygroupconsistedof56children(meanage9.2±1.31,
range: 3.5–17y.) consecutively referred to the pediatric clinic
with a diagnosis of urticaria. Urticaria was diagnosed and
classified according to EAACI/GA
2LEN/EDF/WAO guide-
lines [29]. Among the study patients 39 children were classi-
fi e da sh a v i n gs i n g l ee p i s o d eo fa c u t eu r t i c a r i a .I nr e m a i n i n g
17 patients urticaria occurred intermittently, but recurrently
over months or years and they were classified as suffering
fromrecurrentacuteurticaria(thedurationofsymptom-free
periods was longer than 6 weeks).
Children with physical urticaria were excluded. In all
cases, any known causes of urticaria were ruled out by
appropriate investigations. Each patient underwent the fol-
lowing laboratory tests: full blood count, urine analysis,
hepatic function tests, and serum C-reactive protein (CRP)
concentration. In addition, stool examination for parasites
and the levels of IgA, IgM, IgG, IgE, and D-dimer were
measured. In patients with recurrent urticaria the following
tests were performed: H. pylori antigen evaluation, hepatitis
serology (anti-HCV antibodies, HBsAg), rheumatoid factor,
antinuclear and antithyroid microsomal antibodies, and thy-
roid function tests (thyroid stimulating hormone-TSH and
free thyroxine-fT4). Skin prick tests and/or specific (s) IgE
were performed in patients with a suggestive history for
allergy. In spite of extensive studies, no cause was found
in 23 patients with urticaria (acute urticaria—13 children
and recurrent urticaria—10 children). The identified possible
causes of urticaria were the following: upper respiratory
infection (twenty one patients), food allergy (two), lamblia-
sis (two), and drug allergy (one)—in children with acute
urticaria and recurrent upper respiratory infection (five),
lambliasis (one), and H. pylori infection (one)—in patients
withrecurrenturticaria.Dailyurticariaseverityscores(UAS)
were measured through the assessment of wheals and itching
on a scale 0–3 (the sum of scores: 0–6). A daily UAS of 0–
3 was considered to represent mild urticaria, 3-4 moderate
and 5-6 severe urticaria symptoms. IL-1𝗽, IL-1RA, and IL-18
w e r ee x a m i n e di nt h ew h o l eu r t i c a r i ag r o u pa n ds e p a r a t e l y
in children with the clinical sings of infection and children
freefrominfection.Thecontrolgroupconsistedof41healthy
children (mean age 9.4 ± 1.57, range: 2–17y.) with a negative
history of allergic disease, a normal level of total serum
IgE and negative results of skin prick test to a panel of
aeroallergens (dust mite, mixed grass or tree pollen, cat, and
dog; Allergopharma, Reinbek, Germany). Children included
intothecontrolgroupattendedtheoutpatientpediatricclinic
for nonimmunological, noninflammatory health problems
andneededvenouspuncture.Thepresentstudywasapproved
by the Ethics Committee of the Medical University of Silesia
inKatowiceandwritteninformedconsentwasobtainedfrom
children’s parents.
2.1. Laboratory Measurements
2.1.1. IL-1𝗽, IL-1RA, and IL-18. The serum concentration
of IL-1𝗽/IL-1F2, IL-RA/1F3, and IL-18 was measured with
an enzyme-linked immunoabsorbent assay (ELISA) using
Quantikine kits (R&D Systems, Minneapolis, USA) accord-
ing to the manufacturer’s recommendations. Peripheral
venousbloodwascollectedinto5mLcitratecollectiontubes.
The collected samples were centrifuged for 15 minutes at
1000×g. The serum samples were divided into aliquots and
stored at −80
∘Cu n t i la s s a y e d .W ed i dn o tu s et h es a m p l e s ,
whichwerere-thawed.ThelowerlimitsforIL-1𝗽,IL-1RA,and
IL-18 were 1pg/mL, 18.3pg/mL, and 12.5pg/mL, respectively.
2.1.2. Other Laboratory Investigations. The serum concentra-
tion of total IgE was measured by ELISA using a commercial
kit (Allergopharma, Reinbeck, Germany) according to the
manufacturers’ instructions. The blood eosinophil countsBioMed Research International 3
Table 1: Demographic and clinical characteristics of children with urticaria and healthy children.
Acute urticaria—single episode Recurrent urticaria Healthy children
Number 39 17 41
Age (y.) 8.56 ± 1.67 9.61 ± 2.45 9.36 ± 1.57
M/F 16/23 7/10 17/24
CRP (mg/L) 11.99 ± 7.67
∗ 7.44 ± 8.08
∗∗ 1.05 ± 0.59
WBC (10
9/L) 9.44 ± 1.21 8.19 ± 1.74 7.3 ± 1.54
D-dimer 1.23 ± 0.71
# 0.85 ± 0.81
## nd
𝐸 %( a b s o l u t ec o u n t ,c e l l s / 𝜇L) 1.94 ± 1.94 (236.87 ± 158.7) 1.47 ± 0.95 (136.14 ± 18.13) 1.9 ± 0.96 (177.3 ± 60)
IgE (kU/L) 225.79 ± 102.6 102.82 ± 75.79 72 ± 47.17
IgA (g/L) 1.22 ± 0.17 1.20 ± 0.17 1.13 ± 0.31
IgM (g/L) 1.04 ± 0.09 0.94 ± 0.08 0.99 ± 0.21
IgG (g/L) 8.53 ± 0.59 8.54 ± 0.66 8.63 ± 0.98
Personal allergic disease 9 5
Family allergic disease 5 8
Symptoms suggestive of infection 21 5
UAS 1/2/3
& 12/10/17 11/3/3
Data are shown as mean ± standard error. 𝑃 values from Mann-Whitney 𝑈test.
∗Children with single episode of acute urticaria versus control group 𝑃 < 0.00001.
∗∗Children with recurrent urticaria versus control group 𝑃 < 0.007.
#𝑛=2 2 ,
##𝑛=1 5 .
&Urticaria activity score: 1 mild urticaria (0–3), 2 moderate urticaria (3-4), and 3 severe urticaria (5-6).
were determined using an automatic hematologic analyzer.
SerumCRPconcentrationwasmeasuredbytheturbidimetric
latexagglutinationmethod(C-ReactiveProtein-Latex,Cobas
6000 Roche Diagnostics GmbH, Mannheim, Germany) with
a detection limit of 1.0mg/L. The serum concentration of
fibrin degradation products (D-dimer) was measured by the
latex agglutination method (D-DI Liatest, Diagnostica Stago,
Asni` eres, France) with a limit of detection of 0.22𝜇g/mL.
2.2. Statistical Analysis. Statistical analysis was performed
using software package (Statistica, version 9.0 software pack-
age) and data presented as mean values ± SE. Kruskall-
Wallis and Mann-Whitney 𝑈tests were used for comparisons
between groups. Correlations between variables were tested
usingSpearman’stest.𝑃valueslessthan0.05wereconsidered
statistically significant.
3. Results
Characteristicsofthe56childrenwithacuteurticariaandthe
41healthycontrolsubjectsispresentedinTable1.Bothgroups
were similar in age (𝑃=ns). Positive prick skin test and/or
elevated serum sIgE level had 14 children. In children with
urticaria serum level of CRP was significantly higher than in
the control group. Serum IgE levels in children with single
e p i s o d eo fu r t i c a r i aw a sh i g h e rt h a ni nh e a l t h yc o n t r o l s .
3.1. Serum Levels of IL-1𝗽, IL-1RA, and IL-18 in Children with
Urticaria and Control Subjects. Serum levels of IL-1𝗽,I L -
1RA, and IL-18 in children with urticaria and healthy control
are shown in Table 2.S e r u ml e v e lo fI L - 1 𝗽 did not differ
between children with acute urticaria (single and recurrent
episode) and healthy controls. Children with single episode
of urticaria had significantly higher levels of IL-1RA than
healthy controls (𝑃 < 0.004). Serum level of IL-18 in children
with single episode of urticaria was significantly higher than
in healthy controls and children with recurrent episodes
of urticaria (for both 𝑃 < 0.0005). In the group with
single episode of acute urticaria, in children with symptoms
suggestive of upper respiratory infection (𝑛=2 1 , 53.9%)
both serum IL-1RA and IL-18 was significantly higher than
in healthy children (𝑃 < 0.0001, 𝑃 < 0.00008,r e s p . ) .Th e
formerwasalsohigherthaninnoninfectedurticariachildren
(𝑛=1 8 ,2 9 . 4 % )( 𝑃 < 0.01)( T a b l e2).
Moreover,inallinfectedurticariachildren(singleepisode
and recurrence urticaria, 𝑛=2 6 ) serum levels of IL-1RA and
IL-18 were significantly higher than in healthy controls (𝑃<
0.0004, 𝑃 < 0.001,r e s p . )( d a t an o ts h o w n ) .
The serum concentrations of all examined cytokines in
children with urticaria and without infection (single episode
and recurrence) did not differ as compared to control group.
3.2. Correlation between Serum Levels of IL-1𝗽, IL-1RA, IL-
18, and D-Dimer and Inflammatory Markers in Children
with Single Episode and Recurrent Urticaria. Inchildrenwith
single episode of urticaria serum concentration of IL-1RA
correlated with CRP, D-dimer, and IL-1𝗽 levels (𝑟 = 0.379,
𝑃 = 0.019; 𝑟 = 0.66, 𝑃 = 0.001;a n d𝑟 = 0.34, 𝑃<
0.05, resp.) (Figures 1, 2,a n d3). In addition, in children with
recurrenceofurticariaIL-1RAlevelcorrelatedpositivelywith
D-dimer level and WBC (𝑟 = 0.55, 𝑃 = 0.033, 𝑟 = 0.79,
and 𝑃 = 0.0001) (Figures 4 and 5). Moreover, correlation
between serum IL-1𝗽 level and CPR and D-dimer levels in
children with single episode of urticaria was found (𝑟=0 . 4 ,
𝑃 < 0.05; 𝑟 = 0.35, 𝑃 < 0.05, resp.) (Figures 6 and
7). No correlation between serum cytokine levels and UAS4 BioMed Research International
Table 2: Serum levels of IL-1𝗽, IL-1RA, and IL-18 in children with urticaria and healthy children.
Groups Number IL-1𝗽 (pg/mL) IL-1RA (pg/mL) IL-18 (pg/mL)
Single episode of acute urticaria
All children 39 1.3 ± 0.8 889.1 ± 205.3
∗ 98.0 ± 18.7
∗∗
Children with signs of infection 21 0.7 ± 0.6 1129.8 ± 676.0
# 102.0 ± 47.8
##
Children without infection 18 1.6 ± 0.8 608.3 ± 512.0 93.1 ± 71.3
Recurrent urticaria
All children 17 1.6 ± 0.9 570.5 ± 278.1 56.6 ± 8.6
Children with signs of infection 5 0.8 ± 0.2 512.7 ± 372.2 54.8 ± 16.4
Children without infection 12 1.9 ± 2.1 594.6 ± 242.5 56.9 ± 19.3
Healthy controls 41 1.3 ± 0.3 529.4 ± 114.8 62.2 ± 7.4
Data are shown as mean ± standard error. 𝑃 values from Mann-Whitney 𝑈test.
∗All children with single episode of acute urticaria versus control group, 𝑃 < 0.004.
∗∗All children with single episode of acute urticaria versus control group and children with recurrent urticaria, 𝑃 < 0.0005.
#Patients with single episode of urticaria—children with signs of infection versus children without infection, 𝑃 < 0.01 and versus control group, 𝑃 < 0.0001.
##Patients with single episode of urticaria—children with signs of infection versus control group, 𝑃 < 0.00008.
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Figure 1: Correlation between serum level of IL-1RA and CRP in
children with single episode of acute urticaria.
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Figure 2: Correlation between IL-1RA and D-dimer in children
with single episode of urticaria (all children 𝑛=3 9 ).
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Figure 3: Correlation between IL-1RA and IL-1𝗽 in children with
single episode of urticaria (all children, 𝑛=3 9 ).
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Figure 4: Correlation between serum levels of IL-1RA and d-dimer
in children with recurrence of acute urticaria (all children, 𝑛=1 8 ).BioMed Research International 5
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Figure 5: Correlation between serum level of IL-1RA and WBC in
children with recurrent urticaria (all children, 𝑛=1 8 ).
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Figure 6: Correlation between serum IL-1𝗽 level and CPR concen-
trationinchildrenwithsingleepisodeofacuteurticaria(allchildren,
𝑛=3 9 ).
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Figure 7: Correlation between serum IL-1𝗽 level and D-dimer level
in children with single episode of acute urticaria (all children, 𝑛=
39).
in children with single episode and recurrent urticaria was
observed. In children with single episode of urticaria UAS
correlated with CRP levels (𝑟 = 0.43; 𝑃 < 0.005). We did not
find any correlation between examined cytokines and CRP
and WBC in control group.
3.3. Correlation between Serum Levels of IL-1𝗽, IL-1RA, IL-
18, and D-Dimer and Inflammatory Markers in Infected and
Noninfected Children with Urticaria. Children with single
episode of urticaria and upper respiratory tract infection
showed a positive correlation of IL-1RA concentration with
D-dimer level (𝑟 = 0.6; 𝑃 < 0.04). Children with recurrent
urticaria and infection revealed a positive correlation of IL-
1RA level with WBC and CRP concentration (𝑟 = 0.9; 𝑃<
0.03,f o rb o t h ) .I nc o n t r a s t ,i nc h i l d r e nw i t hs i n g l ee p i s o d eo f
urticaria without infection a positive correlation between IL-
1𝗽 serum level and WBC was found (𝑟=0 . 5 ; 𝑃 < 0.02). In
addition, children with recurrent urticaria without infection
presentedapositivecorrelationofIL-1RAconcentrationwith
WBC and IL-1𝗽 level (𝑟=0 . 7 , 𝑃 < 0.002; 𝑟 = 0.8, 𝑃 < 0.01,
resp.) and between IL-1𝗽 and IL-18 levels (𝑟 = 0.57 and
𝑃 < 0.05).
4. Discussion
The present study was designed to evaluate the circulating
levels of IL-1𝗽, its receptor IL-1RA and IL-18 in children
with single episode, and recurrence of acute urticaria. As
could have been expected, IL-1𝗽 level in serum samples was
low and did not differ between children with urticaria and
healthycontrols.Previousstudies,whichmeasuredtheserum
concentration of IL-1𝗽,h a v ea l s or e v e a l e dt h a ti t sl e v e li n
circulation is usually very low, even in septic shock patients
[30]. Moreover, no concentration of circulating IL-1𝗽 was
detectedinpatientswithinheritedchronicautoinflammatory
syndromes, but increased secretion of IL-1𝗽 was observed
in vitro in such a condition [20]. Interestingly, in CAPS,
in which increased secretion of IL-1𝗽 is due to a single
nucleotide mutation in the NALP3 gene, controlling the
caspase-1 activity, the main source of IL-1, are the mast cells
[23].
In our study, despite low levels, in children with single
episode of urticaria IL-1𝗽 correlated with CRP and D-dimer
levels (marker of coagulation pathway activation). However,
recent studies have documented that overproduction of IL-
1 is important in inflammation because it induces IL-6
excretion, accounts for hepatic acute-phase protein synthesis
(CRP), and contributes to transendothelial passage of neu-
trophils by increasing the surface expression of endothelial
adhesion molecules and production of IL-8 [14, 30, 31]. IL-1𝗽
a p p e a r st op l a yac r u c i a lr o l ei nt h ei n i t i a t i o no fc o a g u l a t i o n
and fibrinolysis [32]. Several of the latest studies focusing
on the relationship between the levels of coagulation and
inflammation markers with the acute phase exacerbation
indicatorsandthedegreeofseverityofchronicurticariahave
been conducted [33–35]. It was shown that D-dimer was
closely related to the activation of urticaria as well as CRP
levels [32, 34].6 BioMed Research International
The potent biological effects of IL-1𝗽 are negatively
regulated by secretory interleukin-1 receptor antagonist (sIL-
1RA). The secretory IL-1RA expression can be induced by
proinflammatorystimulisuchasIL-1𝗽itself,viruses,bacteria,
and microbial products, as well as a variety of immunomod-
ulators such as GMCSF, IFN-𝗽, and IFN-𝗾.A sm e n t i o n e d
above,serumconcentrationofIL-𝗽isusuallylow,andinsuch
casesIL-1RAismeasuredasanindicatoroftheseverityofvar-
ious infections and noninfectious diseases [28]. A significant
increase of IL-1RA was observed during experimental endo-
t o x e m i ai nh u m a n ,i nav a r i e t yo fi n fl a m m a t o r y ,i n f e c t i o u s ,
cardiovascular, and postsurgical conditions, indicating the
importance of this anti-inflammatory protein [36–38]. The
regulation of expression of IL-1RA might play a key role in
terminationofanimmune-mediatedinflammatoryresponse.
Therapy with the recombinant IL-1 receptor antagonist, such
as anakira, results in complete remission in patients with
neutrophilic urticaria and autoinflammatory disorder such
as CAPS, FCAS (familial cold autoinflammatory syndrome),
and DIRA (deficiency of interleukin-1 receptor antagonist)
[23, 39].
In our study, the serum level of IL-1RA was elevated
in children with acute urticaria and evidence of infection,
likely representing a protective response to rise of IL-1𝗽.
Moreover, IL-1RA level was correlated with IL-1𝗽 level, CRP,
andD-dimerlevelsinchildrenwithsingleepisodeofurticaria
a n dW B Ca n dD - d i m e rc o n c e n t r a t i o ni nc h i l d r e nw i t ht h e
recurrence of urticaria.
We documented that IL-1𝗽 and IL-1RA level in infected
and noninfected children with urticaria correlate differently
with D-dimer and the markers of inflammation including
CRP and WBC. Due to the small number of subjects in the
groups the evaluation requires further continuation.
WehavealsoshowedthatserumlevelofIL-18inchildren
with single episode of urticaria and symptoms of upper
respiratory infection was increased as compared to healthy
subjects. Since IL-18 contributes to host defense against
invading pathogens [14] we could not exclude that elevation
of IL-18 similarly to IL-1RA in examined children is an
e a r l ym a r k e ro fa c u t ep h a s eo fi n f e c t i o n .O nt h eo t h e rh a n d ,
this proinflammatory cytokine may play some role in the
pathogenesis of acute urticaria possibly through its capacity
to stimulate histamine release by basophils [12]. IL-18 also
upregulates expression of IL-8 by eosinophils and enhances
recruitment of neutrophils to inflamed tissues [40].
There are several reports that IL-18 plays a pathogeni-
cally important role in chronic inflammatory conditions of
epithelial organs (such as skin, gut, and kidney) and allergic
diseases[17,27].HigherserumlevelsofIL-18havepreviously
been identified in atopic dermatitis and asthmatic subjects
[17, 41]. An elevated level of IL-18 is a prominent feature
of Schnitzler syndrome, a rare disorder characterized by
chronic urticarial rash and monoclonal gammopathy, along
with fever, arthralgia, or bone pain [23]. Overproduction of
IL-18 expression was described in some adults with chronic
spontaneous urticaria [42, 43]b u tn o ti na l ls t u d i e s[ 25].
In conclusion, in this preliminary study in children
we give evidence that serum IL-1RA and IL-18 levels are
i n c r e a s e di ns o m ec h i l d r e nw i t ha c u t eu r t i c a r i a .H o w e v e r ,
further studies should be conducted on a large population
to define a possible pathogenic role of IL-1𝗽,i t sa n t a g o n i s t
receptor IL-1RA and IL-18 in urticaria.
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